Patients who keep up with primary care avoid hospital stays

For older individuals, a visit to the physician can reduce the possibility for a hospital stay down the road. A study, published in The BMJ, analyzes the correlation between continuity of care with primary care physicians and related hospital admissions for older patients.

The study hopes to prove that those in contact with their primary care physician and those who keep up with their care can prevent hospital admission in their elderly years. By staying on track of their own health, patients receive the care they need for everyday health and prevent any surprise trips to the hospital.

Analyzing both primary and secondary care records for 200 clinicians in the Clinical Practice Research Datalink in England, the study included 230,473 patients ages 62 to 82 who have visited their doctors at least twice in two years. Using the provider care index, researchers uncovered the correlation between continuation of primary care and hospital admissions.

Results included:

  • Continuity of care was lowest in organizations with many physicians.
  • Higher rates of continuity of care correlated with fewer hospital admissions.
  • By increasing continuity of care, hospital admissions fell by 6.22 percent.

“Our findings suggest there is opportunity to improve care and reduce hospital admissions among the highest users of healthcare, but there are various explanations of our findings that must first be carefully considered,” concluded Isaac Barker, first author on the study, and colleagues. “One possibility is that when patients receive more continuous care, their doctors might be better able to understand their health needs within time constrained appointments and thus provide care that is more appropriate to the needs of the patient.

"Continuity of care might also promote a more effective and trusting relationship between patients and doctors, leading to a better understanding of health problems and greater adherence to the agreed course of treatment. One would expect these benefits to be felt most keenly in those patients who need to visit the general practitioner frequently. However, it is important to note that identifying a causal mechanism is beyond the scope of this study.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.